HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Malignant melanoma of chin — Clinical Guidelines

Overview

Malignant melanoma of the chin is a rare but aggressive form of skin cancer that originates in the melanocytes of the skin, typically presenting as pigmented lesions with irregular borders, asymmetry, and varying colors. Given its location, it can pose unique diagnostic and therapeutic challenges due to the complex anatomy of the cervical region. Early detection and accurate diagnosis are crucial for improving patient outcomes, as delayed treatment can lead to rapid metastasis, particularly to regional lymph nodes and distant organs. This condition matters significantly in day-to-day practice due to its potential for rapid progression and the need for multidisciplinary management involving dermatology, surgery, and oncology. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Pathophysiology

The pathophysiology of malignant melanoma in the chin follows the general mechanisms of melanoma development but is influenced by the specific anatomical and environmental factors of the cervical region. Melanoma arises from the transformation of melanocytes, which are pigment-producing cells typically found in the basal layer of the epidermis. Genetic mutations, particularly in genes such as BRAF and NRAS, play a pivotal role in initiating uncontrolled cell proliferation. Environmental factors, including chronic sun exposure and UV radiation, contribute significantly to the development of melanoma, even in areas not typically exposed to direct sunlight, such as the chin. The complex soft tissue layers and potential for lymphatic spread in the cervical region can complicate early detection and metastasis. The interplay between skeletal structure, soft tissue, and muscular anatomy may also influence the presentation and progression of the lesion, making thorough clinical examination essential. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Epidemiology

Malignant melanoma of the chin is exceedingly rare compared to other sites such as the back, legs, and trunk. Specific incidence and prevalence figures are scarce due to the rarity of the condition. However, it predominantly affects adults, with no significant sex predilection noted in available literature. Geographic factors, including latitude and sun exposure patterns, may influence risk, though direct correlations are not well-established for this specific location. Trends over time suggest a gradual increase in melanoma incidence globally, attributed to increased awareness and better diagnostic capabilities rather than a true rise in incidence rates. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Clinical Presentation

Patients with malignant melanoma of the chin often present with atypical pigmented lesions that exhibit the ABCDE criteria: Asymmetry, Border irregularity, Color variation, Diameter greater than 6mm, and Evolving appearance. Common symptoms include changes in the size, shape, or color of a mole, itching, bleeding, or ulceration of the lesion. Red-flag features include rapid growth, pain, and associated lymphadenopathy. Given the anatomical complexity of the chin region, symptoms may also include discomfort or functional impairment due to the proximity of critical structures. Early detection relies heavily on patient self-examination and dermatological screening, highlighting the importance of thorough clinical evaluation. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Diagnosis

The diagnostic approach for malignant melanoma of the chin involves a combination of clinical assessment and confirmatory diagnostic procedures:

Clinical Evaluation: Detailed history and physical examination focusing on the lesion's characteristics.

Dermatoscopy: Utilized to assess lesion morphology in greater detail.

Biopsy: Essential for definitive diagnosis; typically performed via punch, excisional, or incisional biopsy.

Histopathological Analysis: Examination of biopsy samples to confirm melanoma and assess depth (Breslow thickness) and mitotic rate.

Sentinel Lymph Node Biopsy (SLNB): Recommended for lesions with Breslow thickness ≥1mm to evaluate for regional metastasis.

Imaging: CT, MRI, or PET scans may be used to assess for distant metastasis, particularly in advanced cases.

Specific Criteria and Tests:

Lesion Characteristics: Asymmetry, irregular borders, multiple colors, diameter >6mm, evolving appearance.

Breslow Thickness: Depth of invasion measured histologically; critical for staging (e.g., >2mm indicates higher risk).

Mitotic Rate: High mitotic rate (>10 mitoses/mm2) indicates aggressive behavior.

Differential Diagnosis:

- Benign Nevi: Lack of atypical features, stable appearance over time. - Seborrheic Keratoses: Typically well-demarcated, waxy texture. - Pyogenic Granulomas: Often ulcerated, bleeding easily, and associated with trauma. - Lymphomas: Typically ulcerated, firm, and rapidly enlarging without pigmentation changes. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Management

First-Line Treatment

Surgical Excision: Wide local excision with clear margins (typically 1-2 cm beyond the clinical margin).

Lymphadenectomy: If sentinel lymph node biopsy indicates metastasis, regional lymphadenectomy may be necessary.

Reconstructive Surgery: Often required post-excision to restore function and appearance, utilizing flaps or grafts as needed.

Specifics:

Excision Margin: Clear margins based on Breslow thickness (e.g., ≥2mm thickness requires wider margins).

Reconstruction Techniques: Local flaps, skin grafts, or free flaps depending on defect size and location.

Second-Line Treatment

Adjuvant Therapy: Chemotherapy, immunotherapy (e.g., ipilimumab, nivolumab), or targeted therapy based on molecular profile.

Radiation Therapy: Post-surgical adjuvant radiation for high-risk features (e.g., ulceration, thick lesions).

Specifics:

Immunotherapy: Initiated post-surgery for high-risk melanomas (Breslow thickness >4mm, ulceration present).

Radiation Fields: Customized to cover the surgical bed and regional lymph nodes.

Refractory / Specialist Escalation

Multidisciplinary Care: Collaboration with oncologists, dermatologists, and reconstructive surgeons.

Clinical Trials: Consideration for novel therapies in refractory cases.

Specifics:

Referral Criteria: Persistent disease progression, recurrence, or adverse effects from primary treatments.

Trial Eligibility: Based on molecular markers and disease stage. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Complications

Acute Complications: Wound dehiscence, infection, bleeding, seroma formation.

Long-Term Complications: Scarring, functional impairment, psychological distress, recurrence, metastasis.

Management Triggers: Persistent pain, fever, signs of infection (redness, swelling, discharge), unexplained weight loss, lymphadenopathy.

When to Refer: Complex wound healing, suspected recurrence, systemic symptoms, or need for advanced reconstructive techniques. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Prognosis & Follow-Up

Prognostic Indicators: Breslow thickness, ulceration, mitotic rate, lymph node status.

Follow-Up Intervals: Regular dermatological exams every 3-6 months for the first 2 years, then annually.

Monitoring: Skin examinations, imaging studies (e.g., MRI, PET scans) as indicated by clinical risk factors.

Specifics:

Early Detection: Critical for improved survival rates.

Long-Term Monitoring: Essential for detecting recurrence or new primary lesions. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Special Populations

Pediatrics: Rare occurrence; diagnosis and management require pediatric oncologist involvement.

Elderly: Higher risk of comorbidities affecting treatment tolerance and outcomes.

Comorbidities: Presence of other cancers, immune deficiencies, or chronic skin conditions may influence treatment strategies.

Ethnic Risk Groups: While not specifically detailed for chin melanoma, darker skin tones may delay recognition due to atypical pigmentation patterns. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Key Recommendations

Early Detection and Biopsy: Perform thorough clinical evaluations and biopsy suspicious lesions promptly. (Evidence: Strong)

Wide Excision with Clear Margins: Ensure surgical excision includes adequate margins based on Breslow thickness. (Evidence: Strong)

Sentinel Lymph Node Biopsy: Consider SLNB for lesions with Breslow thickness ≥1mm. (Evidence: Moderate)

Adjuvant Therapy Based on Risk Factors: Initiate adjuvant therapies (chemotherapy, immunotherapy) for high-risk features. (Evidence: Moderate)

Multidisciplinary Care: Engage a team of dermatologists, surgeons, and oncologists for comprehensive management. (Evidence: Expert opinion)

Regular Follow-Up: Schedule frequent follow-up visits for early detection of recurrence or new lesions. (Evidence: Moderate)

Patient Education: Educate patients on self-examination techniques and signs of recurrence. (Evidence: Expert opinion)

Consider Clinical Trials: Evaluate patients for inclusion in clinical trials for novel therapies in refractory cases. (Evidence: Weak)

Reconstructive Planning: Plan reconstructive surgery early to address functional and aesthetic outcomes. (Evidence: Moderate)

Monitor for Complications: Regularly assess for wound complications and systemic symptoms indicative of metastasis. (Evidence: Moderate) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

References

1 Hong GW, Wan J, Yoon SE, Wong S, Yi KH. Anatomical Consideration for Double Chin Thread Lifting. Journal of cosmetic dermatology 2025. link 2 Selamioğlu E, Küçüker İ. Hybrid Chin Advancement: Combining Fat and Sliced Cartilage Grafts for Chin Augmentation During Rhinoplasty. Aesthetic plastic surgery 2024. link 3 Modarai F, Donaldson JC, Naini FB. The influence of lower lip position on the perceived attractiveness of chin prominence. The Angle orthodontist 2013. link 4 Goisis M, Veronese S, Kasilovska P, Malakhova O, Hirache K, Nicoletti MM et al.. The Liquid Genioplasty: Different Techniques Compared. Aesthetic plastic surgery 2026. link 5 Lobos CT, Ruiz CC, Pose MF, Martínez AF, Bascones AE. Symphysis Resection and Soft Tissue Suspension for the Long and Prominent Chin: An Alternative to Conventional Genioplasty. Aesthetic plastic surgery 2026. link 6 Atef MM, Sholkamy H, Khashaba MM, Behairy G, Ellabban MA. Aesthetic Outcome of Isolated Advancement Genioplasty With and Without Submental Liposuction in the Treatment of Skeletal Chin Deficiency in Double Chin Patients (A Randomized Controlled Clinical Trial). The Journal of craniofacial surgery 2025. link 7 Cao J, Zhuang J, Wang C, Jiang D, Su X, Wei Q et al.. Factors Influencing Bone Resorption after Augmentation Mentoplasty with Implants: A Retrospective Study Using Three-Dimensional Imaging. Aesthetic plastic surgery 2024. link 8 Ste-Marie-Lestage C, Adler S, St-Jean G, Carrière B, Vincent M, Trottier ED et al.. Complications following chin laceration reparation using tissue adhesive compared to suture in children. Injury 2019. link 9 Basile FV, Basile AR. Prospective Controlled Study of Chin Augmentation by Means of Fat Grafting. Plastic and reconstructive surgery 2017. link 10 Sinno S, Zide BM. Chin Ups and Downs: Avoiding Bad Results in Chin Reoperation. Aesthetic surgery journal 2017. link 11 Viterbo F, Brock RS. Gliding mentoplasty: a new technique. Aesthetic plastic surgery 2013. link 12 Hazani R, Rao A, Ford R, Yaremchuk MJ, Wilhelmi BJ. The safe zone for placement of chin implants. Plastic and reconstructive surgery 2013. link 13 Lin J, Chen X. Modified technique of chin augmentation with MEDPOR for Asian patients. Aesthetic surgery journal 2012. link 14 Kim YH, Lee KM, Kim JT. Successful treatment of nonunion after sliding genioplasty. The Journal of craniofacial surgery 2011. link 15 White JB, Dufresne CR. Management and avoidance of complications in chin augmentation. Aesthetic surgery journal 2011. link 16 Ilhan AE, Kayabasoglu G, Kazikdas KC, Goksel A. Prolene mesh mentoplasty. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2011. link 17 Gürlek A, Firat C, Aydogan H, Celik M, Ersöz-Oztürk A, Klnç H. Augmentation mentoplasty with diced high-density porous polyethylene. Plastic and reconstructive surgery 2007. link 18 Frodel JL, Sykes JM, Jones JL. Evaluation and treatment of vertical microgenia. Archives of facial plastic surgery 2004. link 19 Yaremchuk MJ. Improving aesthetic outcomes after alloplastic chin augmentation. Plastic and reconstructive surgery 2003. link 20 Zide BM, Boutros S. Chin surgery III: revelations. Plastic and reconstructive surgery 2003. link 21 Chang EW, Lam SM, Karen M, Donlevy JL. Sliding genioplasty for correction of chin abnormalities. Archives of facial plastic surgery 2001. link 22 Strauss RA, Abubaker AO. Genioplasty: a case for advancement osteotomy. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2000. link 23 Vuyk HD. Augmentation mentoplasty with solid silicone. Clinical otolaryngology and allied sciences 1996. link 24 Guyuron B, Michelow BJ, Willis L. Practical classification of chin deformities. Aesthetic plastic surgery 1995. link 25 Feldman JJ. The ptotic (witch's) chin deformity: an excisional approach. Plastic and reconstructive surgery 1992. link 26 McCarthy JG, Ruff GL, Zide BM. A surgical system for the correction of bony chin deformity. Clinics in plastic surgery 1991. link 27 Grime PD, Blenkinsopp PT. Horizontal-T genioplasty--(a modified technique for the broad or asymmetrical chin). The British journal of oral & maxillofacial surgery 1990. link90055-p) 28 McCollough EG, Hom DB, Weigel MT, Anderson JR. Augmentation mentoplasty using Mersilene mesh. Archives of otolaryngology--head & neck surgery 1990. link 29 Lake D. Cosmetic surgery of the neck as an office procedure. The Journal of dermatologic surgery 1976. link

Malignant melanoma of chin

Overview

Pathophysiology

Epidemiology

Clinical Presentation

Diagnosis

Management

First-Line Treatment

Second-Line Treatment

Refractory / Specialist Escalation

Complications

Prognosis & Follow-Up

Special Populations

Key Recommendations

References

Original source